FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * COLUMN GROUP L P 2. Issuer Name and Ticker or Trading Symbol NGM BIOPHARMACEUTICALS INC [ NGM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
1700 OWENS STREET, SUITE 500
3. Date of Earliest Transaction (MM/DD/YYYY)
8/27/2020
(Street)
SAN FRANCISCO, CA 94158
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/27/2020    P    36359 (1) A $17.79  1736801  D (2)(3)  
Common Stock  8/28/2020    P    26135 (4) A $17.89  1762936  D (2)(3)  
Common Stock                 16166907 (5) D (6)(7)(8)(9)(10)(11)  
Common Stock                 15000  D (12)  
Common Stock                 44000  D (13)  
Common Stock                 190000  I  By Trust (14)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Consists of 17,075 shares of Common Stock held directly by The Column Group III, LP ("TCG III LP") and 19,284 shares of Common Stock held directly by The Column Group III-A, LP ("TCG III-A LP").
(2)  The securities are directly held by TCG III, and indirectly held by The Column Group III GP, LP ("TCG III GP"), the general partner of TCG III. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(3)  The securities are directly held by TCG III-A LP, and indirectly held by TCG III GP, the general partner of TCG III-A LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(4)  Consists of 12,274 shares of Common Stock held directly by TCG III LP and 13,861 shares of Common Stock held directly by TCG III-A LP.
(5)  Consists of 11,103,333 shares of Common Stock held directly by The Column Group, LP ("TCG LP"), 2,265,758 shares of Common Stock held directly by The Column Group II, LP ("TCG II LP"), 100,000 shares of Common Stock held directly by The Column Group GP, LP ("TCG GP"),100,000 shares of Common Stock held directly by The Column Group Management, LP ("TCGM LP"), 1,298,908 shares of Common Stock held directly by Ponoi Capital, LP ("Ponoi LP"), and 1,298,908 shares of Common Stock held directly by Ponoi Capital II, LP ("Ponoi II LP").
(6)  The securities are directly held by TCG LP, and indirectly held by TCG GP, the general partner of TCG LP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(7)  The securities are directly held by TCG II LP, and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(8)  The securities are directly held by TCG GP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(9)  The securities are directly held by TCGM LP. The managing partners of TCGM LP are David Goeddel and Peter Svennilson. The managing partners of TCGM LP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(10)  The securities are directly held by Ponoi LP, and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(11)  The securities are directly held by Ponoi II LP, and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
(12)  These securities are owned solely by Tim Kutzkey.
(13)  The securities are directly held by Peter Svennilson who is a managing partner at The Column Group which invests through TCG II LP, Ponoi LP, Ponoi II LP, TCG III LP and TCG III-A LP (collectively, the "Funds"), among other entities. Under the partnership agreements of the Funds and his agreement with TCGM LP, Mr. Svennilson is deemed to hold certain of the securities for the economic benefit of the Funds and TCGM LP. The Funds and their respective general partners, TCGM LP and the individual managing partners of such entities may be deemed indirect beneficial owners of such securities. Such reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein.
(14)  The securities are directly held by the David V. Goeddel and Alena Z. Goeddel 2004 Trust for which David V. Goeddel and Alena Z. Goeddel serve as co-trustee.

Remarks:
Due to SEC restrictions on the number of reporting owners, this is Form 1 of 2.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
COLUMN GROUP L P
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158
X X

COLUMN GROUP GP, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X

COLUMN GROUP II, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X

Column Group II GP, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X
General Partner
Column Group Management LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X

PONOI CAPITAL, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X

Ponoi Management, LLC
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X
General Partner
Ponoi Capital II, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X

Ponoi II Management, LLC
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X
General Partner
Kutzkey Tim
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

X
Managing Partner

Signatures
/s/ Jennifer J. Carlson, Attorney-in-Fact 8/31/2020
**Signature of Reporting Person Date
NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more NGM Biopharmaceuticals Charts.
NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more NGM Biopharmaceuticals Charts.